Beauty Health CRO granted 746,681 RSUs

Menezes Ronald reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Menezes Ronald reported acquisition or exercise transactions in this Form 4 filing.

Beauty Health Co reported that Chief Revenue Officer Ronald Menezes received a large equity grant in the form of restricted stock units (RSUs). He was awarded 746,681 RSUs of Class A Common Stock at no purchase price as part of his compensation.

Each RSU represents a future right to receive one share of Class A Common Stock, subject to time-based vesting. The award vests in three equal installments on each of the first three anniversaries of the March 20, 2026 grant date, contingent on continued service and certain acceleration rights. Following this grant, Menezes directly owns 1,759,915 shares of the company’s Class A Common Stock.

Insider Trade Summary

Grant/Award: 746,681 shares

Grant/Award 1 txn

Insider Menezes Ronald

Role Chief Revenue Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	746,681	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 1,759,915 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Beauty Health Co (SKIN) disclose about Ronald Menezes in this Form 4?

Beauty Health Co reported that Chief Revenue Officer Ronald Menezes received a grant of 746,681 restricted stock units. These RSUs are a form of equity compensation and will convert into Class A Common Stock only as they vest over time, subject to continued service.

How many restricted stock units did SKIN’s Chief Revenue Officer receive?

Ronald Menezes received 746,681 restricted stock units of Beauty Health Co Class A Common Stock. Each RSU represents a contingent right to one share, with no cash paid per share, and will vest in stages over a three-year period starting from March 20, 2026.

What are the vesting terms of Ronald Menezes’ RSU grant at Beauty Health Co?

The RSUs vest in one-third increments on each of the first three anniversaries of March 20, 2026. Vesting is conditioned on Menezes’ continued service with Beauty Health Co through each vesting date, and the award is also subject to certain acceleration rights described in the grant terms.

How many Beauty Health Co shares does Ronald Menezes hold after this RSU grant?

After the RSU grant, Ronald Menezes is reported to hold 1,759,915 shares of Class A Common Stock directly. This total includes the impact of the 746,681 RSUs awarded, which are structured as equity compensation and will deliver shares as vesting conditions are satisfied over time.

Is Ronald Menezes’ RSU award a market purchase or a compensation grant from SKIN?

The transaction is a compensation-related grant, not a market purchase. The Form 4 shows transaction code “A” and a price of $0.00 per share, indicating a grant or award of RSUs provided by Beauty Health Co as part of his equity-based compensation package.

What type of security is involved in Ronald Menezes’ Form 4 for Beauty Health Co (SKIN)?

The filing involves Class A Common Stock of Beauty Health Co, delivered through restricted stock units. Each RSU represents a contingent right to receive one share of Class A Common Stock in the future, subject to time-based vesting and continued employment with the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/24/2026 - 05:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Menezes Ronald

(Last) (First) (Middle)

C/O THE BEAUTY HEALTH COMPANY

3600 E. BURNETT STREET

(Street)

LONG BEACH CALIFORNIA 90815

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Beauty Health Co [ SKIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Revenue Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/20/2026		A(1)		746,681	A	(1)	1,759,915	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights.

Remarks:

	/s/ Paul Bokota, Attorney-in-fact for Ronald Menezes	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)